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June 20091628 AbstractsMultivariatemodels adjusted for cardiovascular disease risk factors, very
low (0.7) and, in some cases, low ABIs (range, 0.7-0.90) were associated
with increased all-cause mortality, cardiovascular disease mortality, and
combined cardiovascular disease mortality and all-cause mortality at 3 and 6
years. Decreases in ABI of 0.15 between visit 1 and visit 2 were also
associated with an increased risk of all-cause mortality (risk ratio [RR], 2.4)
and cardiovascular disease mortality (RR, 2.8) at 3 years, and combined
cardiovascular disease mortality and all-cause mortality (RR, 1.99) 6 years.
This was independent of the ABI at the initial visit and other cardiovascular
disease risk factors.
Comment: These data provide the first evaluation of the relationship
between PAD progression and cardiovascular disease morbidity and mortal-
ity. A consistent association was documented between PAD progression and
cardiovascular diseasemorbidity andmortality independent of the severity of
PAD and traditional cardiovascular disease risk factors. The study has some
problems. Importantly, progression of ABI is relatively insensitive in the
detection of progression of PAD. PAD can clearly progress without a change
in ABI, and the study did not examine the association of any progression of
PAD, including that not associated with a fall in ABI, with cardiovascular
disease morbidity and mortality. The data also were not stratified for the
location of atherosclerotic disease. Not enough patients with very severe
PAD were included to determine whether a plateau effect exists. It may be
that once a patient’s PAD has become sufficiently severe, further progression
adds no incremental risk to overall mortality.
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Conclusion: Flow and change in flow are not accurate predictors of
thrombosis of polytetrafluoroethylene (PTFE) dialysis access grafts.
Summary: Guidelines of the National Kidney Foundation Kidney
Disease Outcomes Quality Initiative (NDOQI) were updated in 2006 to
indicate that surveillance of dialysis access grafts “may,” rather than “does,”
improve patency and reduce thrombosis of dialysis access grafts (Am JKidney Dis 2006;48:S176-322). Previous studies assessing risk of dialysis
graft thrombosis associated with flow or change in flow assessed risk within
an interval of only one or several measurements. Estimates of risk were
therefore based on a relatively small number of measurements, whereas in
actual practice, risk is assessed repeatedly month after month. The authors
therefore felt that accurate measurement of risk should involve many mea-
surements observed over time. The efficacy of monthly measurements of
flow over time to predict PTFE dialysis access graft failure was addressed by
analyzing monthly flow measurements in 176 patients during a 6-year
period. Logistic regression analysis was used to determine risk of thrombosis
and receiver operating characteristic (ROC) curves were used to determine
accuracy in predicting thrombosis within 1 month.
By ROC analysis, thrombosis predicted by flow had a sensitivity of 53%
at a specificity of 79%, and change in flow had a sensitivity of 58% at a
specificity of 75%. More than half of thromboses were not preceded by a
change in flow measurement. The overall thrombosis rate was 0.69 events
per patient-year. In univariate analysis, low flows (P  .001) and a decrease
in flow (P  .001) were significant predictors of thrombosis in 1 month.
Additional significant predictors were newer graft age (P  .001), previous
graft thrombosis (P  .004), and older patient age (P  .01). Sex, race,
diabetes, graft location, graft configuration, and number of prior thrombo-
ses were not significant. In the multivariable model, only low-flow, decreas-
ing flow, and newer graft age were independent predictors (P  .001).
Comment: Low flow and change in flow were predictors of graft
thrombosis. Despite this, however, more than half of thromboses lacked a
changed in flow measurement, likely because thrombosis occurred before
the change could be measured. Unfortunately, sensitivity for both flow and
change in flow to predict a thrombosis was only slightly more than 50%. The
data therefore indicate that many thromboses of PTFE grafts will not be
predicted by monthly surveillance, and intervention based on surveillance
will likely yield many unnecessary procedures. The authors also postulate
that because angioplasty may stimulate neointimal hyperplasia, acceleration
of stenosis by unnecessary angioplasty may actually promote graft failure and
may explain why surveillance with intervention has not prolonged graft life
in randomized trials.
